Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-Center, Two-Stage, Open-Label, Prospective, Fellow-Eye Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Subjects With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma

Next Previous
Search
Trial Profile

A Multi-Center, Two-Stage, Open-Label, Prospective, Fellow-Eye Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Subjects With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 18 Oct 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Travoprost (Primary)
  • Indications Open-angle glaucoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Envisia Therapeutics

    • Most Recent Events

    • 08 Mar 2019 Status changed from active, no longer recruiting to completed.
    • 26 Jul 2018 Planned End Date changed from 13 Feb 2019 to 12 Feb 2019.
    • 26 Jul 2018 Planned primary completion date changed from 2 Jan 2018 to 12 Feb 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top